Dr. Jacob K. Agamasu, MD

Dr. Agamasu practices at Jacob K Agamasu MD PA in Lake Mary, Florida.

Dr. Agamasu's NPI, 1194774604, was assigned on May 10, 2006. Dr. Agamasu graduated from Semmelweis University in 1991. Dr. Agamasu holds Florida license ME85101.

Dr. Agamasu's primary practice is Jacob K Agamasu MD PA, at 1355 S International Pkwy, Lake Mary, FL 32746 in Seminole County. The practice phone is (407) 804-9616.

Dr. Agamasu's primary practice is Jacob K Agamasu MD PA in Lake Mary, Florida. Dr. Agamasu is also affiliated with AdventHealth Daytona Beach. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Agamasu to 2 more hospitals and 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agamasu practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Agamasu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Agamasu is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Agamasu's licenses on file in 4 states: Florida, Kentucky, District of Columbia and Maryland.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease and deep vein thrombosis (DVT) among the conditions Dr. Agamasu treats.

CMS data shows 1,664 Medicare services from Dr. Agamasu across 12 procedure codes in 2024, for 541 Medicare patients. Medicare paid $117,799 for them.

CMS counts 541 Medicare patients who saw Dr. Agamasu in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agamasu's median patient age at 72, with 51% women.

In 2024, Dr. Agamasu wrote 2,380 Medicare Part D claims for 493 patients. 81% of them were for generic drugs. CMS names the drug for 2,244 of them, across 34 drugs with 11 or more claims each, at $489,368 in total drug cost. In 2023, CMS named 2,135 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Agamasu for performance year 2024, reported individually. Dr. Agamasu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 210 general payments to Dr. Agamasu from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $9,165.

Dmand AI lists 3 awards for Dr. Agamasu, most recently CMS Stage 1 2012 in 2011.

Dr. Agamasu graduated from Semmelweis University in 1991. Dr. Agamasu is a member of ACC and ACP.

Dr. Agamasu is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.